Figure 2.

Network plot of treatment comparisons for Bayesian network meta-analysis. Lines represent trials comparing 2 classes of drug or drugs for (a) clinical remission, (b) end-stage renal disease and doubling of serum creatinine level, and (c) serious adverse events of IgA nephropathy. The size of the nodes (red circles) corresponds to the sample size of the interventions. Comparisons are linked with a line, of which the thickness corresponds to the number of trials that assessed the comparison. MMF, mycophenolate mofetil; RASi, renin−angiotensin system inhibitor; TSP, tonsillectomy combined with steroid pulse therapy.